2022
DOI: 10.1016/j.apsusc.2022.154516
|View full text |Cite
|
Sign up to set email alerts
|

Oxygen-replenishing manganese oxide catalytic nanoparticles on removable pipette surfaces for hypoxic tumour photodynamic therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…Manganese dioxide (MnO 2 ) NPs have been widely used in research attempts to overcome hypoxia as well as its high catalytic activity that converts H 2 O 2 into O 2 and water (He et al, 2021; Idziak et al, 2020; Tran et al, 2022). The potential of MnO 2 NPs to overcome hypoxia was first noticed by Prasad and colleagues that they investigated albumin and MnO 2 NPs complex (A‐MnO 2 NPs) on EMT6 breast tumors and found that this complex can reduce hypoxia by ~45%, and the tumor pH increased from 6.7 to 7.2 (Prasad et al, 2014).…”
Section: Nanotechnology‐mediated Pdtmentioning
confidence: 99%
“…Manganese dioxide (MnO 2 ) NPs have been widely used in research attempts to overcome hypoxia as well as its high catalytic activity that converts H 2 O 2 into O 2 and water (He et al, 2021; Idziak et al, 2020; Tran et al, 2022). The potential of MnO 2 NPs to overcome hypoxia was first noticed by Prasad and colleagues that they investigated albumin and MnO 2 NPs complex (A‐MnO 2 NPs) on EMT6 breast tumors and found that this complex can reduce hypoxia by ~45%, and the tumor pH increased from 6.7 to 7.2 (Prasad et al, 2014).…”
Section: Nanotechnology‐mediated Pdtmentioning
confidence: 99%